February 21, 2020 -- Co-Diagnostics has filed for the CE Mark for its Logix Smart COVID-19 coronavirus reverse transcription polymerase chain reaction (RT-PCR) test.
In a statement, the Salt Lake City-based company said it expects to make the test available this month. Co-Diagnostics was among the first IVD vendors to announce the development of a test for the coronavirus, now known as SARS-CoV-2, which causes the respiratory illness COVID-19.
The assay was developed with proprietary RT-PCR technology that detects RNA in the novel coronavirus in a way that minimizes false positives, according to the company.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current